That's the peptide market right now
[10] [12] High-dose ascorbic acid may diminish the therapeutic effects of certain chemotherapeutic agents, such as bortezomib, due to its antioxidant properties
Any visible change from a clear liquid is a sign of degradation or contamination, and the vial must be discarded
If you have weight-related issues, orforglipron (Foundayo) may be another option
Changing the liquid volume changes concentration, which changes the draw volume for the same target amount
Wegovy has the strongest cardiovascular evidence of any GLP-1 medication thanks to the SELECT trial, which demonstrated a 20% reduction in major adverse cardiac events (heart attack, stroke, and cardiovascular death) in people with obesity and established heart disease